GSS EU Science Funding Gateway

The clinical trials identified by their clinical trial registration numbers are addressed by this topic. 

This funding will ensure that essential clinical trials working to deliver answers of immediate public health relevance in SSA can be concluded. Focussing funding to projects previously supported under the EDCTP2 programme is justified by the advanced stage ongoing studies have reached. It is also justified by ethical issues, such as fully validating the willingness of trial participants to take part in the clinical investigations.

The proposals need to address all of the following:

• Demonstrate the work performed so far, such as number of recruited trial participants, follow-up status as well as analyses to be performed;
• Explain the impact of COVID-19-related delays and disruption in relation to the trial timing (start, recruitment, follow-up period);
• Clearly explain the additional work to be carried out, with a comprehensive plan and budget to conclude the planned studies in a tight timeframe;
• Proposals should present a sound assessment of the feasibility of the planned clinical investigations. Realistic plans for recruiting and following up trial subjects must be presented and corroborated by demonstrated success from previous studies and/or the current study;
• Whilst it is acknowledged that the projects build on previous studies, the proposals should briefly recall the justification of the choice of populations to be enrolled into the trials and explain how they relate to the larger population.